MP Materials Corp (MP)vsVertex Pharmaceuticals Inc (VRTX)

MP

MP Materials Corp

NYSE

$53.74

+0.84%

BASIC MATERIALS · Cap: $9.47B

VRTX

Vertex Pharmaceuticals Inc

NASDAQ

$454.97

+1.42%

HEALTHCARE · Cap: $113.95B

⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Vertex Pharmaceuticals Inc generates 4257% more annual revenue ($12.00B vs $275.46M). VRTX leads profitability with a 32.9% profit margin vs -31.2%. VRTX earns a higher WallStSmart Score of 66/100 (B-).

MP

Avoid

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 7.5

Piotroski: 4/9Altman Z: 1.13

VRTX

Strong Buy

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 10.0Quality: 8.0

Piotroski: 3/9Altman Z: 3.62

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MP.

VRTXUndervalued (+36.5%)

Margin of Safety

+36.5%

Fair Value

$716.04

Current Price

$454.97

$261.07 discount

UndervaluedFair: $716.04Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MP1 strengths · Avg: 10.0/10

Revenue GrowthGrowth

70.0%10/10

Revenue surging 70.0% year-over-year

VRTX6 strengths · Avg: 9.5/10

Profit MarginProfitability

32.9%10/10

Keeps 33 of every $100 in revenue as profit

Operating MarginProfitability

39.6%10/10

Strong operational efficiency at 39.6%

Altman Z-ScoreHealth

3.6210/10

Safe zone — low bankruptcy risk

Market CapQuality

$113.95B9/10

Large-cap with strong market position

Return on EquityProfitability

22.5%9/10

Every $100 of equity generates 23 in profit

Debt/EquityHealth

0.219/10

Conservative balance sheet, low leverage

Areas to Watch

MP4 concerns · Avg: 2.0/10

Return on EquityProfitability

-5.0%2/10

ROE of -5.0% — below average capital efficiency

EPS GrowthGrowth

-55.6%2/10

Earnings declined 55.6%

Free Cash FlowQuality

$-109.26M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth

1.132/10

Distress zone — elevated risk

VRTX3 concerns · Avg: 3.7/10

PEG RatioValuation

2.194/10

Expensive relative to growth rate

P/E RatioValuation

29.3x4/10

Moderate valuation

Piotroski F-ScoreQuality

3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : MP

The strongest argument for MP centers on Revenue Growth. Revenue growth of 70.0% demonstrates continued momentum.

Bull Case : VRTX

The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.

Bear Case : MP

The primary concerns for MP are Return on Equity, EPS Growth, Free Cash Flow.

Bear Case : VRTX

The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

MP profiles as a hypergrowth stock while VRTX is a mature play — different risk/reward profiles.

MP carries more volatility with a beta of 1.62 — expect wider price swings.

MP is growing revenue faster at 70.0% — sustainability is the question.

VRTX generates stronger free cash flow (349M), providing more financial flexibility.

Bottom Line

VRTX scores higher overall (66/100 vs 29/100), backed by strong 32.9% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MP Materials Corp

BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA

MP Materials Corp. The company is headquartered in Las Vegas, Nevada.

Vertex Pharmaceuticals Inc

HEALTHCARE · BIOTECHNOLOGY · USA

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

Compare with Other OTHER INDUSTRIAL METALS & MINING Stocks

MP vs BHP MP vs RIO MP vs VALE MP vs TECK MP vs USAR VRTX vs BHP VRTX vs RIO VRTX vs VALE VRTX vs TECK VRTX vs USAR

Want to dig deeper into these stocks?

Full MP Analysis →Full VRTX Analysis →